MODEL VERDICT
ProQR Therapeutics N.V. (PRQR)
Relative Valuation•Peer multiples, Monte Carlo simulation & quality-adjusted fair value
Popular:
Composite score derived from valuation, quality, and risk factors
Quantitative model thresholds · For educational and research purposes only
| Methodology | Fair Value | vs Current | Weight | Quality | Status |
|---|---|---|---|---|---|
| EV To Revenue 182 industry peers | $3.33 | +126.5% | 4% | B | Data |
| Price / Sales 184 industry peers | $1.61 | +9.5% | 3% | B | Model Driven |
| Weighted Output Blended model output | $7.84 | +433.4% | 100% | 55 | SIGNIFICANTLY UNDERVALUED |
Cross-sectional regression predicting expected multiples based on growth, margins, ROIC, and beta.
| Multiple | Avg | Median | Min | Max | Std |
|---|---|---|---|---|---|
| P/TBV | 3.88 | 3.86 | 2.44 | 5.80 | 1.08 |
| P/B Ratio | 3.88 | 3.86 | 2.44 | 5.80 | 1.08 |
| P/S Ratio | 145.48 | 108.75 | 11.45 | 385.10 | 131.75 |
Based on our peer multiples analysis with 5 valuation metrics, the model estimates PRQR's fair value at $7.84 vs the current price of $1.47, implying +433.4% upside potential. Model verdict: Significantly Undervalued. Confidence: 55/100. This is a quantitative estimate, not a recommendation.
The blended fair value of $7.84 is calculated using four lenses: industry median multiples (40%), historical multiples (30%), forward estimates (20%), and quality-adjusted multiples (10%).
PRQR's current P/E of -3.6x compares to the industry median of 23.5x (45 peers in the group). This represents a -115.5% discount to the industry. The historical average P/E is N/Ax over 0 years. Signal: Deep Discount.
10 analysts cover PRQR with a consensus rating of Buy. The consensus price target is $3.63 (range: $2.00 — $5.00), implying +146.9% upside from the current price. Grade breakdown: Strong Buy (1), Buy (8), Hold (1), Sell (0), Strong Sell (0).
The model confidence score is 55/100, based on: data completeness (3), peer quality (25), historical depth (20), earnings stability (5), and model agreement (2). Cyclicality penalty: -0 points. The model shows moderate agreement across inputs.
The model flags several key risks: (1) Macro/regulatory risks are not captured in this model but remain material.
Peak earnings risk data is not available for PRQR.
No. This dashboard is a quantitative research tool for educational and informational purposes only. It is not investment advice, a solicitation, or a recommendation to buy, sell, or hold any security. The operator of this platform is not a registered investment advisor (RIA), broker-dealer, or financial planner. All model outputs, fair value estimates, signals, and scenarios are the result of automated quantitative computations and should not be construed as professional financial guidance. You should consult a qualified, licensed financial advisor before making any investment decisions. Past model performance is not indicative of future results.